FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Clinical Trials news from FierceBiotech

News

IRX Therapeutics raises $25M Series A

New York-based IRX Therapeutics announced that it has raised $25 million in a Series A. The new money will be used to further develop IRX's cancer and viral disease product platform, including IRX-2 Read more...

Genetic mutation will narrow target cancer groups

The K-ras gene is coming in for some star treatment at the ASCO meeting in Chicago. The gene plays a key role in several cancers, and new research indicates that the common genetic mutation makes Read more...

Sonus, OncoGenex to merge

Bothell, WA-based Sonus Pharmaceuticals is merging with Canada's OncoGenex Technologies and will operate under the name OncoGenex Pharmaceuticals. OncoGenex's CEO Scott Cormack will head up the new Read more...

FDA's delay of Geron ESC trial raises concerns

Getting an embryonic stem cell therapy through clinical trials in the U.S. is looking like an increasingly tough challenge after Geron announced that the FDA is delaying a study of its experimental Read more...

Pfizer gets new cancer team to advance key drugs

With the clock ticking on its patent for Lipitor, Pfizer has turned to a group of new executives to Read more...

EmergingMed matches patients with clinical trials

Recruiting the right number of the right patients for any clinical trial can be a tough prospect. Now there are a host of new efforts to match a patient with a clinical trial, including a service Read more...

Pfizer builds plant, creates jobs in Ireland

Pfizer has finally confirmed earlier reports about its plan to Read more...

Roche expands Memory pact

Roche has exercised its option to further develop and commercialize Memory Pharmaceuticals' drug candidate, MEM 3454, for various neurological and psychiatric disorders. Memory gets a $6 million Read more...

Resolvyx rounds up $25M

Bedford, MA-based Resolvyx has garnered $25 million in a second round of venture capital. QVT Financial LP led the funding round. The money will be used to accelerate Resolvyx's preclinical Read more...

SPOTLIGHT: Angiotech suspends trial

Angiotech suspends trialAngiotech is suspending clinical trials for its Vascular Wrap product candidate in patients undergoing surgery for hemodialysis access, pending a safety review to evaluate an Read more...
Tags: Angiotech  

Get more Clinical Trials coverage at: